Trademark: 79134000
Status Date
Thursday, February 4, 2021
Registration Number
4473215
Registration Date
Tuesday, January 28, 2014
Filing Date
Friday, May 3, 2013
Published for Opposition
Tuesday, November 12, 2013
5 Solutions for medical and clinical use in supporting human and animal cells, tissue and organs; solutions for medical and clinical use and application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation, such preservation being to preserve stem cells and their therapeutic applications; solutions for intravenous use for medical, surgical and veterinary purposes; cultures for growing cells, bacteria [ and viruses ] for medical and clinical purposes; solutions for medical and clinical use for replacing, synthesizing, diluting, rehydrating and expanding human and animal blood, intravascular and extravascular fluids; solutions for medical and clinical use for cell, organ and tissue preservation and the creation of a homeostasis to regulate the environment of cells, organs and tissues; solutions for medical and clinical use for testing drugs on ex vivo perfused human and animal cells, tissue and organs; cell, bacteria and virus growth media, storage media and transportation media for medical or clinical use for stem cell and DNA research and therapy; pharmaceutical transfer agents or components for pharmaceuticals in the form of solutions for medical use for application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation; tissue regenerative pharmaceutical preparations and solutions; stem cells for medical and veterinary purposes; clinical diagnostic preparations for medical or veterinary use; clinical medical reagents; medical diagnostic reagents for proteomic, genomic and metabolomic analysis of tissues, cells, bacteria and viruses and testing the stability of homeostasis within organs, tissues, cells, bacteria and viruses for medical use; * none of the aforesaid * being or * relating to ready-made pharmaceuticals * substances, preparations, compositions or solutions * and none of the aforesaid * being * for use in connection with the * detection or * treatment of herpes and related viral diseases *, or for use with tissue or organs infected by herpes or related viral diseases *
1 Chemicals for use in scientific analysis; chemicals for scientific purposes, namely, making pharmaceutical and veterinary preparations, being media for storing organs, tissue and cells; cell, bacteria and virus growth media for use with cell, bacterial and viral cultures in scientific research
42 [Laboratory services for analytical testing; laboratory services relating to the researching of pharmaceuticals and solutions for medical and surgical use and solutions for supporting human and animal cells, tissue and organs, solutions for use and application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation, solutions for storing human and animal organs, tissues and cells, solutions for replacing, synthesizing, diluting, rehydrating and expanding human and animal blood, intravascular and extravascular fluids, solutions for testing drugs on human and animal cells, tissue and organs, media for stem cell and DNA research and therapy; scientific research; medical transplant research services; medical research; scientific analysis of human tissue and human serum for medical research; stem cell and DNA scientific and medical research services; chemical research and development services; chemical, medical and scientific testing and analysis for medical research purposes; testing of pharmaceutical solutions for medical research purposes; quality control services for others; clinical medical and scientific research; conducting of clinical trials for others; design and development of new technology and products for other uses in medical and veterinary fields;] Information, advisory and consultancy services relating to [ all of the aforesaid] * laboratory services for analytical testing and to scientific research *
The following "none of the aforesaid relating to ready-made pharmaceuticals and none of the aforesaid for use in connection with the treatment of herpes and related viral diseases" should be inserted at end of the class 5.
In the statement, Page 1, line 16, "and viruses" should be deleted. In the statement, Page 2, line 1, after "aforesaid" "being or" should be inserted. In the statement, Page 2, lines 1-2, after "pharmaceuticals" "substances, preparations, compositions or solutions" should be inserted. In the statement, Page 2, line 2, after "aforesaid" "being" should be inserted. In the statement, Page 2, line 3, before "treatment" "detection or" should be inserted. In the statement, Page 2, line 3, after "diseases" ", or for use with tissue or organs infected by herpes or related viral diseases" should be inserted.
Color is not claimed as a feature of the mark.
Oct 12, 2023
International Registration Renewed
Jan 28, 2023
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Feb 5, 2021
Notice Of Partial Cancellation Sec. 7 Surrender Emailed
Feb 4, 2021
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Feb 4, 2021
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Feb 4, 2021
Cancelled Sec. 7 - Partial
Dec 18, 2020
New Representative At Ib Received
Nov 25, 2020
Case Assigned To Post Registration Paralegal
Jul 28, 2020
Teas Section 71 & 15 Received
Jul 28, 2020
Teas Section 7 Request Received
Jan 28, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 13, 2018
Invalidation Reviewed - No Action Required By Office
Apr 10, 2018
Partial Invalidation Of Reg Ext Protection Created
Aug 10, 2017
Correction Under Section 7 ¿ Processed
Aug 10, 2017
Case Assigned To Post Registration Paralegal
Aug 10, 2017
Limitation From The Ib Examined And Entered
Jun 16, 2017
Limitation Of Goods Received From Ib
Oct 27, 2016
Change Of Name/Address Rec'd From Ib
Mar 12, 2016
Invalidation Reviewed - No Action Required By Office
Jan 7, 2016
Partial Invalidation Of Reg Ext Protection Created
May 7, 2015
Correction Under Section 7 ¿ Processed
May 7, 2015
Assigned To Paralegal
May 7, 2015
Limitation From The Ib Examined And Entered
May 1, 2015
Limitation Of Goods Received From Ib
Nov 14, 2014
New Representative At Ib Received
Jul 4, 2014
Final Decision Transaction Processed By Ib
Jun 17, 2014
Final Disposition Notice Sent To Ib
Jun 17, 2014
Final Disposition Processed
Apr 28, 2014
Final Disposition Notice Created, To Be Sent To Ib
Jan 28, 2014
Registered-Principal Register
Dec 13, 2013
New Representative At Ib Received
Nov 12, 2013
Official Gazette Publication Confirmation E-Mailed
Nov 12, 2013
Published For Opposition
Oct 23, 2013
Notification Of Notice Of Publication E-Mailed
Oct 8, 2013
Law Office Publication Review Completed
Oct 7, 2013
Assigned To Lie
Sep 25, 2013
Approved For Pub - Principal Register
Sep 24, 2013
Teas/Email Correspondence Entered
Sep 24, 2013
Correspondence Received In Law Office
Sep 24, 2013
Teas Response To Office Action Received
Sep 17, 2013
Refusal Processed By Ib
Aug 27, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Aug 27, 2013
Refusal Processed By Mpu
Aug 25, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Aug 24, 2013
Non-Final Action Written
Aug 22, 2013
Assigned To Examiner
Aug 13, 2013
Application Filing Receipt Mailed
Aug 9, 2013
New Application Office Supplied Data Entered
Aug 8, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
